Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Biodesix, Bioyong to Commercialize Blood Test for Lung Cancer

Facebook Twitter LinkedIn Email Comments
BOULDER, Colo., Jan. 13, 2017 — Medical diagnostics provider Biodesix Inc. and spectrometry developer Bioyong Technology Co. Ltd. have entered into an international collaboration agreement where Bioyong will develop and commercialize a version of Biodesix’s VeriStrat proteomic blood test, a precision medicine diagnostic for patients with non-small cell lung cancer (NSCLC).

Bioyong will pay Biodesix approximately $38 million over the course of the collaboration. The system will be designed for clinical use in China, with potential expansion into other Asia-Pacific countries.

With nearly 850,000 new lung cancer diagnoses predicted in 2020, China represents approximately 37 percent of new cases worldwide.

“We believe that cancer is a global problem,” said David Brunel, CEO of Biodesix. “Patients and their physicians everywhere want cancer treatment that is grounded in precision medicine including therapy selection that reflects the full spectrum of biological information provided by our multivariate, molecular and proteomic assays. By collaborating with Bioyong, we are taking a major step toward making our technology available to a large portion of the world’s lung cancer patients.”

Biodesix is a molecular diagnostics company advancing the development of innovative blood tests in oncology to enable precision medicine. Bioyong Technology is a developer of mass spectrometry technologies.
Jan 2017
BiodesixBioyong Technologydiagnosticscancerblood testAsia-PacificAmericasBusinessBiophotonics

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.